SANUWAVE Health Inc.

NASDAQ: SNWV · Real-Time Price · USD
39.09
1.31 (3.47%)
At close: Aug 15, 2025, 12:47 PM

SANUWAVE Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
39.19M 36.19M 32.63M 29.3M 24.89M 22.41M 20.4M 18.9M 18.12M 17.32M 16.74M 15.5M 15.06M 14.09M 13.01M 10.61M 8.85M 6.02M
Cost of Revenue
8.74M 8.46M 8.08M 8.15M 7.27M 6.55M 6.22M 5.62M 4.81M 4.71M 4.33M 3.92M 4.87M 4.82M 4.99M 4.16M 3.15M 2.13M
Gross Profit
30.45M 27.73M 24.55M 21.16M 17.63M 15.86M 14.17M 13.29M 13.3M 12.62M 12.41M 11.58M 10.19M 9.27M 8.02M 6.45M 5.7M 3.9M
Operating Income
7.34M 7.45M 5.42M 3.93M 1.45M 389K -539K -4.59M -5.9M -9.04M -8.95M -8.3M -9.8M -11.64M -14.14M -25.14M -27.57M -26.8M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-38M -32.49M -31.34M -385K -3.43M -17.25M -25.8M -52.2M -28.91M -18.95M -10.29M -11.59M -15.42M -26.73M -27.23M -36.07M -37.83M -32.86M
Net Income
-38.03M -32.52M -31.37M -389K -3.43M -17.25M -40.61M -67M -42.29M -27.42M -6.49M -10.39M -15.66M -31.88M -29.86M -36.1M -37.85M -32.87M
Selling & General & Admin
21.6M 18.76M 17.67M 15.99M 14.96M 14.31M 13.57M 16.62M 17.95M 20.34M 20.03M 17.86M 18.01M 19.04M 20.28M 22.88M 24.1M 21.47M
Research & Development
717K 718K 673K 662K 666K 610K 578K 508K 500K 532K 567K 672K 812K 913K 1.1M 1.18M 1.32M 1.31M
Other Expenses
619K 799K 607K 386K 180K 9K 198K 389K 578K 779K 766K 1.36M 1.17M 960K 784K 336.09K 663.21K 727.98K
Operating Expenses
22.94M 20.28M 18.95M 17.04M 15.81M 15.1M 14.53M 17.69M 19.21M 21.66M 21.36M 19.89M 19.99M 20.91M 22.17M 24.4M 26.09M 23.51M
Interest Expense
6.32M 8.22M 13.64M 14.12M 14.31M 14.9M 15.62M 16.88M 16.86M 15.44M 14.35M 12.58M 10.59M 9.12M 7.09M 5.72M 4.64M 3.51M
Selling & Marketing Expenses
7.26M 6.62M 6.32M 5.94M 4.77M 4.72M 4.9M 5.87M 6.48M 7.17M 7.47M 7.18M 7.68M 8.53M 8.59M 9.2M 8.42M 6.33M
Cost & Expenses
31.85M 28.74M 27.22M 25.37M 23.45M 22.02M 20.94M 23.5M 24.02M 26.36M 25.7M 23.81M 24.86M 25.73M 27.15M 28.56M 29.24M 25.64M
Income Tax Expense
27K 27K 165.72K 142.72K 142.72K 142.72K 14.81M 14.8M 13.38M 8.47M -3.8M -1.2M 236K 5.15M 2.63M 1.86M 2.61M 2.6M
Shares Outstanding (Basic)
8.56M 8.55M 8.54M 3.19M 3.15M 3.1M 1.12B 2.38M 1.55M 1.53M 1.48M 1.5M 1.44M 1.4M 1.39M 1.38M 1.38M 1.38M
Shares Outstanding (Diluted)
9.17M 8.55M 8.54M 3.19M 3.7M 3.1M 1.12B 2.38M 1.55M 1.53M 1.48M 1.5M 2.33M 1.4M 1.39M 1.38M 1.38M 1.38M
EPS (Basic)
-8.52 -6.56 -7.36 -5.85 -9.31 -15.14 -21.18 -25.05 -15.86 -10.97 -7.22 -10.16 -13.15 -21.79 -21.79 -26.47 -33.97 -30.22
EPS (Diluted)
-8.63 -6.87 -7.67 -6.16 -9.62 -15.14 -21.18 -25.05 -15.86 -11.4 -7.65 -10.59 -13.58 -21.79 -21.79 -26.47 -33.97 -30.22
EBITDA
-22.01M -22.99M -24.91M 6.37M 3.52M -1.36M -9.15M -33.58M -10.13M -10.29M -3.52M -7.28M -13.13M -17.18M -18.9M -17.33M -26.89M -23.26M
EBIT
-23.17M -24.11M -26.06M 5.39M 2.53M -2.35M -10.18M -34.63M -12.09M -4.61M 2.29M -1.47M -6.57M -18.29M -20.14M -23.72M -33.2M -29.35M
Depreciation & Amortization
1.16M 1.12M 1.15M 984K 993K 987K 1.03M 1.05M 1.32M 1.32M 1.25M 1.24M 1.13M 1.16M 1.24M 1.54M 1.44M 1.23M